[Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition].

Anti-Inflammatory Agents / adverse effects Anticoagulants / adverse effects Cyclooxygenase 2 Inhibitors / therapeutic use Endoscopy, Gastrointestinal Helicobacter Infections / diagnosis Hemorrhage / complications Humans Peptic Ulcer / diagnosis Platelet Aggregation Inhibitors / adverse effects Proton Pump Inhibitors / therapeutic use
Anti-inflammatory agents Anticoagulants Antiplatelet agent Guideline Peptic ulcer non-steroidal

Journal

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
ISSN: 2233-6869
Titre abrégé: Korean J Gastroenterol
Pays: Korea (South)
ID NLM: 101189416

Informations de publication

Date de publication:
25 09 2020
Historique:
received: 24 06 2020
revised: 08 07 2020
accepted: 08 07 2020
entrez: 24 9 2020
pubmed: 25 9 2020
medline: 12 8 2021
Statut: ppublish

Résumé

The Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers were previously developed under co-work with the Korean College of

Identifiants

DOI: 10.4166/kjg.2020.76.3.108 PMID: 32969360
pubmed: 32969360
pii: kjg.2020.76.3.108
doi: 10.4166/kjg.2020.76.3.108
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Anticoagulants 0
Cyclooxygenase 2 Inhibitors 0
Platelet Aggregation Inhibitors 0
Proton Pump Inhibitors 0

Types de publication

Journal Article Practice Guideline Review

Langues

kor

Sous-ensembles de citation

IM

Pagination

108-133

Auteurs

Moon Kyung Joo (MK)

Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

Chan Hyuk Park (CH)

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Joon Sung Kim (JS)

Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Jae Myung Park (JM)

Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Ji Yong Ahn (JY)

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Bong Eun Lee (BE)

Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.

Jeong Hoon Lee (JH)

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Hyo-Joon Yang (HJ)

Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Yu Kyung Cho (YK)

Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Chang Seok Bang (CS)

Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.

Beom Jin Kim (BJ)

Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

Hye-Kyung Jung (HK)

Department of Internal Medicine, College of Medicine, Ewha Woman's University, Seoul, Korea.

Byung-Wook Kim (BW)

Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Yong Chan Lee (YC)

Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
ORCID: 0000-0001-8800-6906

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-inflammatoires › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Anticoagulants › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antirhumatismaux › Anti-inflammatoires non stéroïdiens › Inhibiteurs des cyclooxygénases › Inhibiteurs de la cyclooxygénase 2 › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Endoscopie › Endoscopie digestive › Endoscopie gastrointestinale › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Helicobacter › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Hémorragie › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies de l'estomac › Ulcère peptique › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Antiagrégants plaquettaires › [Clinical Guidelines for Drug-induced Peptic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de la pompe à protons › [Clinical Guidelines for Drug-induced Peptic...